The results demonstrated that the overall survival time of CCA patients with a high expression of KLK11 was significantly shorter than those with a low expression of KLK11 (414 vs. 809 days, respectively; p = 0.048) (Figure 5B). Here, KLK11 is linked to cholangiocarcinoma.